Standard psychiatric care, including medication management and psychotherapy, can be an important part of mental health treatment. But for some people, symptoms continue despite sincere effort, multiple medication trials, regular therapy, or a combination of approaches.
That can be discouraging. It can also lead people to believe they have exhausted every reasonable option.
At H3O Wellness, we work with patients in Twin Falls and across southern Idaho who need a more detailed conversation about what has not helped, what may be contributing to ongoing symptoms, and what treatment options may be appropriate to consider next. When standard care has not provided enough relief, the next step is not necessarily “more of the same.” It may be a careful reassessment and a broader discussion of available evidence-informed treatments.
When It May Be Time to Reassess Your Treatment Plan
Persistent symptoms do not always mean that treatment has failed. Depression and other mental health conditions can be affected by many factors, including diagnosis, medication tolerability, treatment duration, psychotherapy fit, medical conditions, sleep, substance use, major stressors, and access to consistent care.
A thorough evaluation can help clarify whether a current treatment plan needs adjustment or whether another approach should be discussed.
For some patients, the next step may still involve medication management, psychotherapy, lifestyle support, or treatment for a co-occurring condition. For others, an advanced treatment option may be appropriate to explore.
The goal is not to rush into a procedure or assume one path is better than another. It is to understand the full clinical picture and make decisions that fit the individual patient.
What Interventional Psychiatry Can Add
Interventional psychiatry refers to treatments that go beyond routine medication management and traditional talk therapy. These approaches may involve medical devices, monitored medications, or structured treatment models designed for people whose symptoms have not improved enough with standard care.
At H3O Wellness, advanced treatment discussions begin with psychiatric services and an individualized assessment. We consider symptoms, treatment history, current medications, medical needs, safety considerations, practical concerns, and personal preferences before recommending a next step.
For patients who are primarily exploring treatment-resistant depression, our overview of advanced depression treatment options in Idaho may help introduce the differences among several available approaches.
Treatment Options We May Discuss
Every treatment has its own evidence base, treatment schedule, safety considerations, and potential limitations. No option is right for every patient.
TMS Therapy
TMS therapy is an FDA-cleared, noninvasive treatment used for depression. It uses magnetic pulses to stimulate targeted brain regions involved in mood regulation.
TMS does not require anesthesia and is typically delivered through a series of outpatient sessions. It may be worth discussing for adults with depression who have not had enough benefit from medication or who have struggled with medication side effects.
TMS requires a meaningful time commitment, and response varies by person. A consultation can help clarify what treatment may involve, whether it may be appropriate, and how it could fit alongside other care.
SPRAVATO® Treatment
SPRAVATO® treatment uses esketamine, a prescription nasal spray administered in a certified healthcare setting under direct medical supervision.
SPRAVATO® is FDA-approved for adults with treatment-resistant depression, either as monotherapy or in conjunction with an oral antidepressant. It also has an FDA-approved use, alongside an oral antidepressant, for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior.
Treatment requires monitoring after each dose because side effects can include sedation, dissociation, dizziness, nausea, and temporary blood-pressure changes. Patients should also plan for transportation home after a treatment visit.
Our guide to what a SPRAVATO® treatment visit may involve provides additional information about the practical side of care.
SPRAVATO® does not replace emergency mental health care, hospitalization, or crisis support when those services are clinically needed.
Ketamine Treatment
Ketamine treatment may be discussed for some patients after a careful psychiatric and medical evaluation.
Ketamine’s psychiatric use is off-label, meaning it is not FDA-approved specifically for depression or other mental health conditions. Research suggests it may help some adults with treatment-resistant depression, but it is not appropriate for everyone, and long-term treatment planning should be individualized.
A discussion about ketamine should include your diagnosis, prior treatment history, current medications, substance-use history, physical-health considerations, possible risks, alternatives, and goals for care.
Ketamine should not be presented as a guaranteed solution, a replacement for all other mental health treatment, or emergency care for someone who is unable to stay safe.
Ketamine-Assisted Psychotherapy
Ketamine-assisted psychotherapy combines ketamine treatment with structured psychotherapy and integration work. The purpose is to place the medication experience within a broader therapeutic process that includes preparation, support, and follow-up.
Research on ketamine-assisted psychotherapy is still developing. Some early findings are encouraging, but treatment models vary and more rigorous research is needed to clarify who may benefit most and how treatment should be structured.
Our overview of ketamine-assisted psychotherapy in Idaho explains more about how this approach may differ from ketamine treatment alone.
Choosing the Right Treatment Is Not a Formula
TMS, SPRAVATO®, ketamine treatment, and ketamine-assisted psychotherapy are different approaches. They are not interchangeable, and none should be selected based solely on what is newest, fastest, or most discussed online.
A thoughtful recommendation should consider:
- Your diagnosis and symptom pattern
- Previous medications and therapy experiences
- Current medical conditions and medications
- Safety considerations
- Time commitment and transportation needs
- Insurance and out-of-pocket considerations
- Personal preferences and treatment goals
Some patients may be better served by continuing psychiatric care, changing medication strategies, pursuing psychotherapy, or addressing another concern that may be affecting their mental health. Others may be candidates to discuss an interventional option.
Shared decision-making matters. You should understand the potential benefits, limitations, risks, practical requirements, and alternatives before beginning any treatment.
Frequently Asked Questions
How do I know whether advanced psychiatric treatment may be appropriate?
An evaluation is the best place to start. Advanced treatment may be worth discussing when symptoms have continued despite standard care, but the right option depends on your diagnosis, treatment history, health needs, and preferences.
What is the difference between TMS, SPRAVATO®, and ketamine treatment?
TMS is a device-based, FDA-cleared treatment for depression. SPRAVATO® is an FDA-approved esketamine nasal spray that requires supervised administration and monitoring. Ketamine treatment may be discussed off-label in some psychiatric situations. Each option has different treatment schedules, safety considerations, and evidence.
Can I continue seeing my current therapist or prescribing provider?
Many patients benefit from ongoing therapy or medication management while exploring additional treatment options. Your care plan should be coordinated thoughtfully, and communication with other members of your care team may be appropriate with your permission.
How long does treatment take?
Treatment schedules vary. TMS generally involves multiple outpatient sessions over several weeks. SPRAVATO® treatment includes an initial treatment phase followed by a maintenance schedule when clinically appropriate. Ketamine treatment plans and psychotherapy schedules also vary by patient.
Will insurance cover advanced psychiatric treatment?
Coverage varies by treatment and insurance plan. TMS and SPRAVATO® may require prior authorization or specific eligibility criteria. Ketamine treatment is often not covered for psychiatric use because it is off-label. We encourage patients to review their benefits and discuss practical questions with our team before beginning care.
What should I do if I am in crisis or cannot stay safe?
Do not wait for a routine appointment or rely on a blog for crisis care. Call or text 988 to reach the Suicide & Crisis Lifeline, call 911, or go to the nearest emergency department if you are in immediate danger or cannot stay safe.
Key Takeaways
- Persistent mental health symptoms deserve a careful reassessment, not self-blame.
- Interventional psychiatry may include treatment options beyond standard medication management and psychotherapy.
- TMS is an FDA-cleared, noninvasive treatment for depression.
- SPRAVATO® is FDA-approved for adults with treatment-resistant depression and requires supervised administration and monitoring.
- Ketamine treatment and ketamine-assisted psychotherapy involve off-label psychiatric use and require individualized evaluation.
- No treatment can guarantee results, but patients whose current care has not provided enough relief may still have reasonable options to explore.
Moving Forward When Standard Care Has Not Been Enough
When depression or another mental health concern has not improved as hoped, it can be difficult to know what to do next. You do not have to decide on a treatment option before asking for help.
At H3O Wellness, we provide thoughtful psychiatric evaluation and individualized treatment planning for patients exploring TMS, SPRAVATO®, ketamine treatment, ketamine-assisted psychotherapy, and ongoing psychiatric care.
The first step is an informed conversation about your history, your goals, and what may be appropriate for you. To get started, contact our team.
About H3O Wellness
H3O Wellness is an interventional psychiatry and mental wellness practice serving patients in Twin Falls, Burley, and surrounding southern Idaho communities. We provide patient-centered care focused on respect, dignity, comprehensive evaluation, and individualized treatment planning.
Medical Disclaimer
The content of this blog is provided for educational purposes only and does not constitute medical advice. Individual results vary, and no treatment outcome can be guaranteed. The information presented here is not a substitute for professional medical evaluation, diagnosis, or treatment.
If you are experiencing a mental health crisis or are concerned about your safety, seek immediate help from emergency services or a qualified healthcare professional. Treatments described in this article may not be appropriate for every patient. Always discuss your symptoms, medical history, and treatment options with a licensed provider before making healthcare decisions.
Works Cited
Jha, M. K., & Mathew, S. J. (2023). Pharmacotherapies for treatment-resistant depression: How antipsychotics fit in the rapidly evolving therapeutic landscape. American Journal of Psychiatry, 180(3), 190–199.
Simpson, R. J., & Juruena, M. F. (2026). Effectiveness of ketamine-assisted psychotherapy as a treatment for treatment-resistant depression: A systematic review. Psychopharmacology. Advance online publication.
U.S. Department of Veterans Affairs, & U.S. Department of Defense. (2022). VA/DoD clinical practice guideline for the management of major depressive disorder.
U.S. Food and Drug Administration. (2022). NeuroStar TMS Therapy System: 510(k) summary.
U.S. Food and Drug Administration. (2025). SPRAVATO® (esketamine) nasal spray prescribing information.